Baselake Partners reported a 9.4% stake in Neuphoria Therapeutics NEUP · 222,222 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 9.4%
Last report: First report
Shares held: 222,222 sh
Class: Common Stock, $0.00001 par value per share
Stock: Neuphoria Therapeutics NEUP
Holder: Baselake Partners
Event date: 25/10/27
Filed: 25/10/31

First 5%+ report · 9.4% stake

Neuphoria Therapeutics trades, last 26 weeks

What else happened in Neuphoria Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/27~25/11/26

Baselake Partners's other 5% stake reports

Baselake Partners
5% stakeKiora Pharmaceuticals
5% stake
Kiora Pharmaceuticals
KPRX
5.8% stake
257,500 sh
5.8% stake
Filed 09/17
Baselake Partners
5% stakeTherapeuticsMD
5% stake
TherapeuticsMD
TXMD
6.8% stake
790,703 sh
6.8% stake
Filed 08/05
Baselake Partners
5% stakePassage BIO
5% stake
Passage BIO
PASG
7.3% stake
235,058 sh
7.3% stake
Filed 06/25
Baselake Partners
5% stakeTherapeuticsMD
5% stake
TherapeuticsMD
TXMD
5.2% stake
607,181 sh
5.2% stake
Filed 04/06
Baselake Partners
5% stakeLeonaBio
5% stake
LeonaBio
LONA
1.9% stake
75,789 sh
1.9% stake
Filed 02/06